<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5167132 Figure_2-A</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Immunoblotting analysis of Neuro2a (N2a) cells expressing Sig1R-FLAG variants.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-B</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Cycloheximide chase analysis on N2a cells expressing Sig1R-FLAG. Quantitative data of immunoblotting for the levels of Sig1R-FLAGprotein and its variants during the cyclohexamide chase were plotted as mean &#177; SEM of three independent experiments (upper panel). Representative immunoblots for the levels of Sig1R-FLAGproteins were shown (lower panel). **: p &lt; 0.01, *: p = 0.0216 in E102Q vs. wild-type (WT); ##: p &lt; 0.01, #: p &lt; 0.05 in L95fs vs. WT. A one-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-C</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. N2a cells transfected with Sig1R-FLAG variants were incubated with MG-132 (10 &#181;M) or the combination of E64d and pepstatin A (5 &#181;g/mL each) (E64d/PepA) for 8 h. The relative mean levels of Sig1R-FLAG variants determined by immunoblotting from three independent experiments were plotted as mean &#177; SEM (upper panel). The representative immunoblots were shown (lower panel). *: p &lt; 0.05 vs. no inhibitor control. A one-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-E</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E and F. Subcellular localization of inositol 1,4,5-triphosphate receptor type 1 (IP3R1) and type 3 (IP3R3) in N2a cells stably expressing human IP3R3 (N2a-IP3R3 cells, E). IP3R1 and IP3R3 in the isolated fractions were identified by immunoblotting with the specific antibodies as indicated. Proper fractionation of these samples was confirmed by the fraction specific markers as indicated.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-F</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>E and F. Subcellular localization of inositol 1,4,5-triphosphate receptor type 1 (IP3R1) and type 3 (IP3R3) in HeLa cells (F). IP3R1 and IP3R3 in the isolated fractions were identified by immunoblotting with the specific antibodies as indicated. Proper fractionation of these samples was confirmed by the fraction specific markers as indicated.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-G</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Interaction of IP3R3 with wild-type Sig1R or E102Q ALS-linked Sig1R mutant. Sig1R-FLAG variants were transfected in N2a-IP3R3 cells, and IP3R3 was co-immunoprecipitated using an anti-FLAG antibody and identified by immunoblotting with the specific antibodies as indicated.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-H</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Suppression of Sig1R by siRNA. Lysates of N2a cells transfected with control siRNA (siCtrl) or siRNA against Sig1R (siSig1R) for 24 h were blotted. Similar results were obtained from three independent experiments. Paired t-test was used for statistical analysis.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-I</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I</infon>
    <passage>
      <offset>0</offset>
      <text>I and J. Cytoplasmic calcium (Ca2+) flux in N2a or human IP3R3 stably expressing N2a (N2a-IP3R3) cells. siCtrl or siSig1R was transfected to N2a or N2a-IP3R3 cells, then cytoplasmicCa2+ flux were determined with fluo-4 and Case12-mito, respectively. The fluorescent intensity was normalized to the intensity in resting state at 0 s, and plotted as mean &#177; SD.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-J</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-J</infon>
    <infon key="sourcedata_figure_dir">Figure_2-J</infon>
    <passage>
      <offset>0</offset>
      <text>I and J. mitochondrial (J) calcium (Ca2+) flux in N2a or human IP3R3 stably expressing N2a (N2a-IP3R3) cells. siCtrl or siSig1R was transfected to N2a or N2a-IP3R3 cells, then mitochondrial Ca2+ flux were determined with fluo-4 and Case12-mito, respectively. The fluorescent intensity was normalized to the intensity in resting state at 0 s, and plotted as mean &#177; SD.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_2-K-L</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 2-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_2-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>K and L. Cytoplasmic (K) or mitochondrial (L) Ca2+ flux in N2a-IP3R3 cells. siCtrl or siSig1R was transfected with or without the Sig1R-FLAG variants. The data are obtained and plotted as described above. n = 10 each. **: p &lt; 0.01, *: p &lt; 0.05 (I-L). Two-way ANOVA with subsequent post hoc Tukey's test (I-J).</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_3-A</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. The levels of Sig1R in the lumbar spinal cord (LSC) or brain of Sig1R&#8722;/&#8722;, Sig1R+/&#8722;, or Sig1R+/+ mice at 5 months old. Representative immunoblots obtained from three independent experiments are shown. Asterisk denotes non-specific bands.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_3-B-C</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B and C. Sig1R-deficient SOD1G85Rmice (SOD1G85R/Sig1R&#8722;/&#8722;) exhibited accelerated onset of the disease (B) and shortened survival time (C) compared to SOD1G85Rmice with one or two copies of Sig1R (SOD1G85R/Sig1R+/&#8722;, SOD1G85R/Sig1R+/+). Open circles indicate Sig1R knockout mice (Sig1R&#8722;/&#8722;) that never developed motor neuron disease but that were sacrificed at 396 days of age (n = 8). Mean onset or survival times of mice with &#177;SD are shown on the top of Kaplan-Meyer curves. **: p &lt; 0.01, *: p &lt; 0.05, log-rank test. n = 14 (SOD1G85R/Sig1R+/+), 29 (SOD1G85R/Sig1R+/&#8722;), 17 (SOD1G85R/Sig1R&#8722;/&#8722;).</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_3-D-E</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 3-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D and E. Body weights were lost earlier both in male (D) and female (E) of SOD1G85R/ Sig1R&#8722;/&#8722;mice. Data are shown as mean &#177; SD. *: p &lt; 0.05 in SOD1G85R/Sig1R+/+ vs. SOD1G85R/Sig1R&#8722;/&#8722;, &#8224;: p &lt; 0.05 in SOD1G85R/Sig1R+/&#8722; vs. SOD1G85R/Sig1R&#8722;/&#8722;. n = 8 (SOD1G85R/Sig1R+/+), 13 (SOD1G85R/Sig1R+/&#8722;), 8 (SOD1G85R/Sig1R&#8722;/&#8722;) in male (D), and n = 6 (SOD1G85R/Sig1R+/+), 16 (SOD1G85R/Sig1R+/&#8722;), 9 (SOD1G85R/Sig1R&#8722;/&#8722;) in female (E). The used animals were the same in the panels B and C. The animals used in the panels D and E were the same in the panels B and C. *: p &lt; 0.05 in SOD1G85R/Sig1R+/+ vs. SOD1G85R/Sig1R&#8722;/&#8722;, &#8224;: p &lt; 0.05 in SOD1G85R/Sig1R+/&#8722; vs. SOD1G85R/Sig1R&#8722;/&#8722;. Two-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_3-F</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Decreased performance on the rotarod test was observed in SOD1G85R/ Sig1R&#8722;/&#8722;mice. The test was performed at 0-30 rpm with 0.1 rpm/s acceleration every week. Data are shown as mean &#177; SD. **: p &lt; 0.0001 in SOD1G85R/Sig1R+/+ vs. SOD1G85R/Sig1R&#8722;/&#8722;, &#8224; &#8224;: p &lt; 0.0001 in SOD1G85R/Sig1R+/&#8722; vs. SOD1G85R/Sig1R&#8722;/&#8722;. The used animals were the same in the panels B-E. Two-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_3-G-H</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 3-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G and H. Motor function of WT (Sig1R+/+) and Sig1R knockout (Sig1R&#8722;/&#8722;) mice at 5 or 12 months old was evaluated by the rotarod test (0-30 rpm, accelerated at 0.1 rpm/s). Average time on the rotating rod was plotted. Error bars denote SD. Unpaired t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_4-A-B</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A and B. N2a cells expressing SOD1WT, SOD1G85R or SOD1G93A (A), or spinal cords of WT or mutant SOD1 transgenic mice at end-stage (B) were fractionated as described in Materials and methods section (Cyto: cytoplasm, P1: nuclei and debris, Mito: mitochondria, MAM: mitochondria-associate membrane, P3: microsomal fraction). Proper fractionation was confirmed by the fraction specific markers as indicated, and also shown in Fig EV1 A-E. An asterisk denotes non-specific bands.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_4-C</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Tissue and cell-type specific accumulation of mutant SOD1 at the MAM. Brain, liver, or primary astrocytes from SOD1G93Amice were fractionated and blotted as in Figures 4A and B (Upper panel). Quantification of SOD1 proteins at the MAM relative to ones in the cytoplasm was performed from immunoblotting data with an anti-human SOD1 antibody in (B) and the top panel of (C), and the data are plotted as mean &#177; SEM from three independent experiments (Lower panel). **: p &lt; 0.01 vs. SOD1WTspinal cord. A one-way ANOVA with subsequent post hoc Tukey's test. Proper fractionation of these samples was confirmed in Fig EV 1F-H.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_4-D</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Mutant SOD1 prevented association of ER with mitochondria. Isolated ER (P3: microsomal fraction) and mitochondria of N2a cells expressing wild-type (WT) or G85R (85) SOD1 for 48 h were mixed and incubated. Mitochondrial pellets after centrifugation were analyzed by immunoblotting using anti-PDI (ER marker) and anti-VDAC (mitochondrial marker), respectively. All these results were confirmed by three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_5-A-B</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A and B. Time course analyses of mutant SOD1 levels at the MAM in SOD1G93A mouse spinal cords (A) and brains (B). Immunoblots show levels of mutant SOD1 protein in the indicated fractions at various time points (left panels). Quantitative data at the right were plotted as mean &#177; SEM of three independent experiments. Arrows indicate a rapid reduction in SOD1 level at the MAM just following the onset of disease.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_5-C-D</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C and D. Time course analyses of mutant SOD1 accumulation at the MAM in SOD1G85R (C) and SOD1G37R (D) mouse spinal cords. Quantitative data from three independent experiments were plotted (bottom). The arrows in the bottom panel are the same as in A and B.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_5-E</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Time course analyses of MAM-specific proteins at MAM and in the whole lysates of SOD1G93A mouse spinal cords.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_6-A-I</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 6-A-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-I</infon>
    <passage>
      <offset>0</offset>
      <text>A-I. Immunofluorescence staining of spinal cords and brains from non-transgenic (Non-Tg), SOD1 transgenic, or Sig1R&#8722;/&#8722;mice. Transverse sections of mousespinal cords (A, D-I) or sagittal sections of mouse brains (B, C) were stained using anti-Sig1R (white), &#946;III-tubulin (red) and IP3R3 (green) antibodies. Note that Sig1R and IP3R3 are co-localized in the motor neurons of the anterior horn (A) and the hypoglossal nucleus (B), and IP3R3 was not expressed in hippocampal neurons (C). Mutant SOD1 induced aggregation of Sig1R and mislocalization of IP3R3 in anterior horn neurons (D-G), while their abnormalities were not observed in SOD1WTmotor neurons (H). Mislocalization of IP3R3 was also observed in Sig1R&#8722;/&#8722;mouse spinal cords (I). Scale bars: 50 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_6-J-K</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 6-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_6-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>J and K. Representative electron micrographs of the MAM (J) (double-headed arrows) in motor neurons of 12 months-old Non-Tg, SOD1G85R or Sig1R&#8722;/&#8722;mice. Note that ER-mitochondria contacted areas were reduced in both SOD1G85R or Sig1R&#8722;/&#8722;mice. Quantification of the mitochondria surface associated to ER was calculated in K. For quantification, 13-19 motor neurons and 224-316 mitochondria with MAM in each animal (n = 2) were analyzed. Data are expressed as mean &#177; SEM. Double asterisk means p &lt; 0.0001 vs Non-Tg. A one-way ANOVA with subsequent post hoc Tukey's test. Scale bars: 300 nm.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_6-L</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 6-L</infon>
    <infon key="sourcedata_figure_dir">Figure_6-L</infon>
    <passage>
      <offset>0</offset>
      <text>L. The levels for IP3R3 and calreticulin were decreased in the MAM fractions of Sig1R&#8722;/&#8722;mouse brains. MAM fractions and whole tissue lysates of Sig1R+/+ or Sig1R&#8722;/&#8722;mouse brains were immunoblotted. Representative blots from three independent experiments are shown.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_7-A</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. N2a cells were transfected with WT or mutant SOD1 in the presence or absence of IP3R3. Plotted viability of the cells measured by a neurotoxicity assay revealed that IP3R3 is involved in cell vulnerability against mutant SOD1. Data are expressed as mean &#177; SEM from three independent experiments, triplicated in each experiment. **: p &lt; 0.01, *: p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_7-B-C-D</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 7-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-G. Calpain activity (B-D) were measured in N2a-IP3R3 cells expressing Sig1R-FLAG (B and E), SOD1 (C and F), or both (D and G). Mean &#177; SEM from three independent experiments is plotted. *: p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_7-E-F-G</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 7-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>B-G. intracellular ATP levels (E-G) were measured in N2a-IP3R3 cells expressing Sig1R-FLAG (B and E), SOD1 (C and F), or both (D and G). Mean &#177; SEM from three independent experiments is plotted. *: p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_7-H-I</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 7-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_7-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>H and I. Calpain activity in vivo was determined by the cleavage of spectrin &#945;II. Calpain-cleaved 150 kDa fragment of spectrin &#945;II in mouselumbar spinal cord or brain (H) was normalized to &#946;-actin (I). Quantitative data in immunoblotting analyses are plotted as mean &#177; SEM from three independent experiments. **: p &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_8-A-B</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 8-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A and B. Cytoplasmic (A) or mitochondrial (B) Ca2+ flux was measured in N2a-IP3R3 cells treated with PRE-084 (5 &#181;M) or NE-100 (5 &#181;M) for 1 h prior to fluorescent imaging. Cytoplasmic and mitochondrialCa2+ flux were detected by fluo-4 and Case12-mito, respectively. The fluorescent intensity was normalized by the resting state at 0 s, and plotted as mean &#177; SD. n = 10 each. **: p &lt; 0.01, *: p &lt; 0.05. Two-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_8-C</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C and D. Calpain activity were measured in N2a-IP3R3 cells treated with PRE-084 (5 &#181;M) or NE-100 (5 &#181;M) for 24 h. Data are plotted as mean &#177; SEM from three independent experiments. *: p &lt; 0.05 vs. mock control. A one-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_8-D</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>C and D. intracellular ATP levels were measured in N2a-IP3R3 cells treated with PRE-084 (5 &#181;M) or NE-100 (5 &#181;M) for 24 h. Data are plotted as mean &#177; SEM from three independent experiments. *: p &lt; 0.05 vs. mock control. A one-way ANOVA with subsequent post hoc Tukey's test.</text>
    </passage>
  </document>
  <document>
    <id>5167132 Figure_8-E-F</id>
    <infon key="sourcedata_document">2440</infon>
    <infon key="doi">10.15252/emmm.201606403</infon>
    <infon key="pmc_id">5167132</infon>
    <infon key="figure">Figure 8-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E and F. SOD1G93Amice were intraperitoneally administered with saline or PRE-084 (0.25 mg/kg, 3 times per week) from postnatal day 35 to 95. Lumbar spinal cord sections were stained by using anti-Sig1R (white), IP3R3 (green), and &#946;III-tubulin (red) at 95 days old. Arrowheads indicate the neurons with normal distribution of Sig1R and IP3R3. Scale bars: 50 &#181;m.</text>
    </passage>
  </document>
</collection>
